Cochlear Implant Atlas
CI Atlas · Speech-Coding Strategies: The Complete Lineage · Module 13

13The Present Commercial Landscape: Four Makers, Five Philosophies

Today's commercial strategies each preserve a different extra cue on top of the shared CIS/n-of-m foundation. This module synthesises the present landscape — ACE and PACE, MED-EL high-rate CIS and FS4, Advanced Bionics HiRes/F120, Oticon Medical's pulse-width-coding Crystalis, and Nurotron's APS/Symphony — and explains why incremental gains have plateaued.

TCochlear: ACE and the psychoacoustic PACE/MP3000

Cochlear's default ACE selects 8-12 amplitude maxima of 10-12 (or up to 22) bands at a default 900 pps using CIS-principle interleaved pulses PACE / MP3000 operates like ACE (n-of-m) but replaces simple energy-maxima selection with a psychoacoustic masking model, stimulating the most perceptually relevant channels With PACE, reducing the selected bands from 8 to 4 could maintain speech-understanding performance ACE is comparable to CIS and superior to SPEAK in challenging conditions.[2005][2006]

+8Percentage-point HiRes 120 gain on HINT sentences in +8 dB noise (p=.043) [2009]
3/10Subjects improving any spectral cue with Fidelity120 after >=8 weeks (Donaldson 2011) [2011]

CMED-EL and Advanced Bionics

MED-EL processors run a 12-channel implant with 12 logarithmically spaced band-pass filters and can generate up to 18,180 pulses/sec aggregate (about 1515 pps per channel in the 12-channel CIS implementation), supporting simultaneous 12-electrode stimulation and a high-rate spectral-maxima option MED-EL's FS4 adds apical temporal-fine-structure coding on the four most apical channels at roughly 1500-2000 pps Advanced Bionics' Clarion CII/HiRes uses 16 electrodes with half-wave rectification and no low-pass filter at about 2800 pps Advanced Bionics HiRes Fidelity 120 adds current steering for up to 120 virtual channels at 1800-2900 pps per electrode.[2006][2014]

Four makers, five design choices — tap a cell

DefaultPeak-pickingMaxFineCurrentCochlearAdv. BionicsMED-ELOticon Med.

Cochlear · Default strategy: ACE (n-of-m)

Today's commercial strategies are recombinations of the same lineage. Cochlear ships ACE (n-of-m peak-picking); Advanced Bionics ships high-rate CIS-like coding with current steering; MED-EL ships fine-structure coding on a long array; the historical fourth maker ran a CIS-based scheme. Despite the differing philosophies, head-to-head differences between devices are small — because, as the chapter's opening insisted, the patient dominates the outcome. Schematic.

COticon Medical Crystalis and Nurotron APS/Symphony

Oticon Medical's Crystalis uses an FFT filter bank regrouped into 20 channels with N-of-M selection (default N=8) but modulates pulse WIDTH (with fixed pulse height) rather than pulse amplitude, at an adjustable rate of 250-1000 pps and a default of 500 pps, using a distributed all-polar return Nurotron's 26-electrode system (24-channel intracochlear array) runs APS, an N-of-M peak-selection strategy with 6-8 active stimulation channels, integrating the c-tone algorithm Nurotron's Symphony adds current steering to create virtual intermediate channels with peak picking Both Nurotron strategies aim to represent temporal fine structure.[2015][2017]

CWhy incremental gains have plateaued

Despite differing strategies and electrodes, present commercial devices show no significant overall performance difference Increasing electrodes beyond about 4-8 effective channels, current steering and fine-structure coding have yielded only modest or unproven speech-in-noise gains Current spread, channel interaction, the ~300 Hz electric temporal-pitch ceiling and variable neural survival fundamentally cap information transfer Strategies based on spectral signal analysis outperformed explicit feature extraction, which is why all present strategies share the CIS/n-of-m core.[2004][2006]

Loudness in the pulse — amplitude or width?

louder → taller pulse

A pulse delivers charge as amplitude × duration, so loudness can be carried by either dimension. Most strategies — CIS, ACE, HiRes — fix the pulse width and modulate amplitude. Oticon Medical's Crystalis instead held amplitude constant and modulated pulse width, a distinctive charge-coding choice argued to give more uniform loudness growth across electrodes. Same physics, different knob. Schematic.

TThe current commercial landscape and its honest evidence base

Modern devices pair high-rate envelope coding with current steering: HiRes 120 (Fidelity120) creates intermediate virtual channels between physical electrodes (Firszt 2009). HiRes 120 produced significant gains on CNC words (57%->63%, p=.023), HINT-in-noise (61%->69%, p=.043), and BKB-SIN (10.2->9.2 dB, p=.037), but not HINT-in-quiet, and 7/8 preferred it (Firszt 2009). Fidelity120 improves spectral-ripple resolution (3.42 vs 2.31 ripples/octave) but worsens a temporal fine-structure cue, all 9 listeners falling to chance on Schroeder-phase (Drennan 2010). A skeptical within-subjects study found no overall strategy effect on speech (small HiRes edge for consonants); only 3/10 improved any spectral cue with F120 (Donaldson 2011). In the MED-EL line, fine-structure FSP offers telephone and music benefits but is statistically equivalent to envelope HDCIS on standard speech tests in independent data (Dillon 2016; Magnusson 2011).[2009][2010]

TBy the numbers

Standard HiRes vs HiRes 120: Speech Scores in Quiet and Noise

0255075100Percent correctCNC wordsHINT quietHINT +8 dB noise
Test conditionHINT +8 dB noiseStandard HiRes61%HiRes 120 (Fidelity120)69%

Today's commercial strategies layer current steering onto high-rate envelope coding. In Firszt 2009 (n=8) HiRes 120 gave significant gains on CNC words (57%->63%, p=.023) and HINT-in-noise (61%->69%, p=.043) but not in quiet (90% vs 92%, NS). Donaldson 2011 found no overall strategy effect, underscoring the mixed real-world evidence. Verified means from Firszt 2009.

Case 14.13 · The Present Commercial Landscape
A device-selection committee notes that across MED-EL, Cochlear, Advanced Bionics and Oticon Medical, large head-to-head trials show no clearly superior strategy for average speech-in-quiet outcomes, despite very different coding philosophies.

What is the best engineering explanation for this convergence in outcomes?

Self-assessment — Module 132 questions
Question 1

What is distinctive about how Oticon Medical's Crystalis encodes stimulation magnitude?

Question 2

How does PACE/MP3000 differ from standard ACE?

Tracked locally in your browser — see /progress for the dashboard.